2013 Q3 Form 10-Q Financial Statement
#000114420413045716 Filed on August 14, 2013
Income Statement
| Concept | 2013 Q3 | 2013 Q2 | 2012 Q2 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $270.0K | $740.0K | $450.0K |
| YoY Change | -38.64% | 64.44% | -29.69% |
| % of Gross Profit | |||
| Research & Development | $804.0K | $742.0K | $385.0K |
| YoY Change | 9.84% | 92.73% | -34.75% |
| % of Gross Profit | |||
| Depreciation & Amortization | $30.00K | $20.00K | $40.00K |
| YoY Change | -25.0% | -50.0% | 0.0% |
| % of Gross Profit | |||
| Operating Expenses | $1.076M | $1.485M | $833.0K |
| YoY Change | -8.19% | 78.27% | -31.72% |
| Operating Profit | -$1.081M | -$1.500M | -$829.0K |
| YoY Change | -6.0% | 80.94% | |
| Interest Expense | |||
| YoY Change | |||
| % of Operating Profit | |||
| Other Income/Expense, Net | -$10.00K | -$20.00K | $0.00 |
| YoY Change | -150.0% | -100.0% | |
| Pretax Income | -$1.080M | -$1.500M | -$830.0K |
| YoY Change | -6.09% | 80.72% | -23.85% |
| Income Tax | $1.000K | $18.00K | $1.000K |
| % Of Pretax Income | |||
| Net Earnings | -$1.082M | -$1.518M | -$830.0K |
| YoY Change | -5.91% | 82.89% | -24.55% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$98.63K | -$149.5K | -$97.19K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 152.7M shares | 128.6M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2013 Q3 | 2013 Q2 | 2012 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $5.120M | $2.540M | $840.0K |
| YoY Change | 7.11% | 202.38% | -71.03% |
| Cash & Equivalents | $329.0K | $755.0K | $843.0K |
| Short-Term Investments | $4.790M | $1.780M | |
| Other Short-Term Assets | $60.00K | $140.0K | $140.0K |
| YoY Change | 20.0% | 0.0% | 180.0% |
| Inventory | |||
| Prepaid Expenses | $55.00K | $135.0K | |
| Receivables | $500.0K | $620.0K | $420.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $5.672M | $3.290M | $1.400M |
| YoY Change | 7.22% | 135.0% | -55.27% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $267.0K | $263.0K | $300.0K |
| YoY Change | -1.11% | -12.33% | -21.05% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $20.00K | ||
| YoY Change | 100.0% | ||
| Other Assets | $270.0K | $240.0K | $130.0K |
| YoY Change | 80.0% | 84.62% | 44.44% |
| Total Long-Term Assets | $540.0K | $504.0K | $450.0K |
| YoY Change | 25.58% | 12.0% | -8.16% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $5.672M | $3.290M | $1.400M |
| Total Long-Term Assets | $540.0K | $504.0K | $450.0K |
| Total Assets | $6.212M | $3.794M | $1.850M |
| YoY Change | 8.6% | 105.08% | -48.9% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $446.0K | $373.0K | $520.0K |
| YoY Change | 134.74% | -28.27% | 73.33% |
| Accrued Expenses | $710.0K | $606.0K | $790.0K |
| YoY Change | -14.46% | -23.29% | 31.67% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $1.386M | $1.200M | $1.450M |
| YoY Change | 26.0% | -17.24% | 13.28% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $290.0K | $240.0K | $150.0K |
| YoY Change | 81.25% | 60.0% | 66.67% |
| Total Long-Term Liabilities | $290.0K | $240.0K | $150.0K |
| YoY Change | 81.25% | 60.0% | 66.67% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.386M | $1.200M | $1.450M |
| Total Long-Term Liabilities | $290.0K | $240.0K | $150.0K |
| Total Liabilities | $1.677M | $1.439M | $1.600M |
| YoY Change | 33.1% | -10.06% | 16.79% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | |||
| YoY Change | |||
| Common Stock | $55.73M | $52.46M | |
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $4.535M | $2.360M | $250.0K |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $6.212M | $3.790M | $1.850M |
| YoY Change | 8.6% | 104.86% | -48.9% |
Cashflow Statement
| Concept | 2013 Q3 | 2013 Q2 | 2012 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.082M | -$1.518M | -$830.0K |
| YoY Change | -5.91% | 82.89% | -24.55% |
| Depreciation, Depletion And Amortization | $30.00K | $20.00K | $40.00K |
| YoY Change | -25.0% | -50.0% | 0.0% |
| Cash From Operating Activities | -$713.0K | -$1.063M | -$419.0K |
| YoY Change | -33.61% | 153.7% | -47.63% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $31.00K | $46.00K | $9.000K |
| YoY Change | 121.43% | 411.11% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$3.010M | -$10.00K | $0.00 |
| YoY Change | -100.0% | ||
| Cash From Investing Activities | -$3.039M | -$57.00K | -$9.000K |
| YoY Change | 21607.14% | 533.33% | -10.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $3.326M | $0.00 | $0.00 |
| YoY Change | -32.12% | -100.0% | |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | $3.326M | $7.000K | $126.0K |
| YoY Change | -33.85% | -94.44% | 152.0% |
| NET CHANGE | |||
| Cash From Operating Activities | -$713.0K | -$1.063M | -$419.0K |
| Cash From Investing Activities | -$3.039M | -$57.00K | -$9.000K |
| Cash From Financing Activities | $3.326M | $7.000K | $126.0K |
| Net Change In Cash | -$426.0K | -$1.113M | -$302.0K |
| YoY Change | -110.81% | 268.54% | -60.26% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$713.0K | -$1.063M | -$419.0K |
| Capital Expenditures | $31.00K | $46.00K | $9.000K |
| Free Cash Flow | -$744.0K | -$1.109M | -$428.0K |
| YoY Change | -31.62% | 159.11% | -46.5% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00005 | |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00005 | |
| CY2013Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
800000000 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
800000000 | shares |
| CY2013Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
152714176 | shares |
| CY2013Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
152714176 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
150085035 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
150085035 | shares |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1317000 | USD |
| CY2012Q4 | us-gaap |
Nontrade Receivables Current
NontradeReceivablesCurrent
|
742000 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
46000 | USD |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4874000 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
17000 | USD |
| CY2013Q2 | bcli |
Severance Pay Fund
SeverancePayFund
|
215000 | USD |
| CY2012Q4 | bcli |
Severance Pay Fund
SeverancePayFund
|
172000 | USD |
| CY2013Q2 | us-gaap |
Long Term Investments
LongTermInvestments
|
241000 | USD |
| CY2012Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
189000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
247000 | USD |
| CY2013Q2 | us-gaap |
Assets
Assets
|
3794000 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
5310000 | USD |
| CY2013Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
373000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
358000 | USD |
| CY2013Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
606000 | USD |
| CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
605000 | USD |
| CY2013Q2 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
221000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
176000 | USD |
| CY2013Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1200000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1139000 | USD |
| CY2013Q2 | us-gaap |
Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
|
239000 | USD |
| CY2012Q4 | us-gaap |
Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
|
189000 | USD |
| CY2013Q2 | us-gaap |
Liabilities
Liabilities
|
1439000 | USD |
| CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
1328000 | USD |
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-06-30 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| CY2013Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
263000 | USD |
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Entity Registrant Name
EntityRegistrantName
|
BRAINSTORM CELL THERAPEUTICS INC. | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001137883 | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
| dei |
Trading Symbol
TradingSymbol
|
BCLI | ||
| CY2013Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
152714176 | shares |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1697000 | USD | |
| bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
16000 | USD | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1302000 | USD | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
958000 | USD | |
| CY2013Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | USD |
| CY2013Q2 | us-gaap |
Nontrade Receivables Current
NontradeReceivablesCurrent
|
620000 | USD |
| CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
755000 | USD |
| CY2013Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
135000 | USD |
| CY2013Q2 | us-gaap |
Assets Current
AssetsCurrent
|
3290000 | USD |
| CY2013Q2 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
26000 | USD |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
152546703 | shares |
| CY2013Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD |
| CY2012Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD |
| CY2013Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
52456000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | USD |
| CY2012Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
51483000 | USD |
| CY2012Q4 | us-gaap |
Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
|
47508000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3982000 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5310000 | USD |
| CY2013Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
1780000 | USD |
| CY2012Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
2769000 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
2566000 | USD | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
1712000 | USD | |
| us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
0 | USD | |
| us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
0 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2582000 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
18000 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5000 | USD | |
| us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-2600000 | USD | |
| us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-1702000 | USD | |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD | |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2600000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-1702000 | USD | |
| us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.02 | ||
| us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.01 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
27453000 | USD | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
20053000 | USD | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
47506000 | USD | |
| bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
2470000 | USD | |
| us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
132000 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
100000 | USD | |
| us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-49944000 | USD | |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-164000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-50108000 | USD | |
| CY2013Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
742000 | USD |
| CY2012Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
385000 | USD |
| CY2013Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
743000 | USD |
| CY2012Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
448000 | USD |
| CY2013Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1485000 | USD |
| CY2012Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
833000 | USD |
| CY2013Q2 | bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
15000 | USD |
| CY2013Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
0 | USD |
| CY2012Q2 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
0 | USD |
| CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1500000 | USD |
| CY2012Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-829000 | USD |
| CY2013Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
18000 | USD |
| CY2012Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000 | USD |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-1518000 | USD |
| CY2012Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-830000 | USD |
| CY2004 | us-gaap |
Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
|
6000 | USD |
| CY2004 | bcli |
Stock Cancelled During Period Value
StockCancelledDuringPeriodValue
|
0 | USD |
| CY2005 | bcli |
Stock Issued During Period For Private Placement In June
StockIssuedDuringPeriodForPrivatePlacementInJune
|
60000 | USD |
| CY2005 | bcli |
Adjustments To Additional Paid In Capital Contribution Of Capital
AdjustmentsToAdditionalPaidInCapitalContributionOfCapital
|
7000 | USD |
| CY2005 | bcli |
Stock Issued During Period For Private Placement Value Issues One
StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne
|
1418000 | USD |
| CY2005 | bcli |
Stock Cancelled During Period Value
StockCancelledDuringPeriodValue
|
0 | USD |
| CY2005 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
0 | USD |
| CY2005 | bcli |
Amortization Of Deferred Stock Based Compensation Related To Shares And Options Granted To Employees
AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees
|
584000 | USD |
| CY2005 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
17506000 | USD |
| CY2005Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
704000 | USD |
| CY2006Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7911000 | USD |
| CY2006Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1816000 | USD |
| CY2012Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-9000 | USD |
| CY2005 | bcli |
Stock Issued Expenses
StockIssuedExpenses
|
25000000 | USD |
| CY2012Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
128078347 | shares |
| CY2012Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.01 | |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.01 | |
| CY2012Q2 | bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
-4000 | USD |
| bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
-15000 | USD | |
| CY2004 | bcli |
Price Per Share Of Stock Issued During Period To Purchase Mineral Option
PricePerShareOfStockIssuedDuringPeriodToPurchaseMineralOption
|
0.065 | |
| CY2005 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement In June
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJune
|
0.01 | |
| CY2005 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement Issue One
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne
|
0.75 | |
| CY2008 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement Issue One
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne
|
0.1818 | |
| CY2007 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement Issue One
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne
|
0.1818 | |
| CY2006 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement In May
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInMay
|
0.80 | |
| CY2006 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement In July
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJuly
|
0.6 | |
| CY2006 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement In September
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInSeptember
|
0.8 | |
| CY2006 | bcli |
Price Per Share Of Stock Issued During Period For Private Placement In December
PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInDecember
|
0.8 | |
| CY2008 | bcli |
Price Per Share Of Subscription Of Shares During Period For Private Placement
PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement
|
0.1818 | |
| CY2010 | bcli |
Price Per Share Of Subscription Of Shares During Period For Private Placement
PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement
|
0.12 | |
| bcli |
Stock Issued During Period For Cash In September Price Per Share
StockIssuedDuringPeriodForCashInSeptemberPricePerShare
|
0.00188 | ||
| bcli |
Stock Issued During Period For Cash In March Price Per Share
StockIssuedDuringPeriodForCashInMarchPricePerShare
|
0.0375 | ||
| CY2000Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
| CY2001Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
68000 | USD |
| CY2002Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
53000 | USD |
| CY2003Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21000 | USD |
| CY2004Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-31000 | USD |
| bcli |
Stock Issued During Period For Cash In September
StockIssuedDuringPeriodForCashInSeptember
|
17000 | USD | |
| bcli |
Stock Issued During Period For Cash In March
StockIssuedDuringPeriodForCashInMarch
|
60000 | USD | |
| CY2004 | bcli |
Stock Issued During Period Value Stock Splits
StockIssuedDuringPeriodValueStockSplits
|
0 | USD |
| CY2002 | bcli |
Adjustments To Additional Paid In Capital Contribution Of Capital
AdjustmentsToAdditionalPaidInCapitalContributionOfCapital
|
11000 | USD |
| CY2003 | bcli |
Adjustments To Additional Paid In Capital Contribution Of Capital
AdjustmentsToAdditionalPaidInCapitalContributionOfCapital
|
15000 | USD |
| CY2004 | bcli |
Adjustments To Additional Paid In Capital Contribution Of Capital
AdjustmentsToAdditionalPaidInCapitalContributionOfCapital
|
15000 | USD |
| CY2006 | bcli |
Stock Issued During Period For Private Placement In May
StockIssuedDuringPeriodForPrivatePlacementInMay
|
149000 | USD |
| CY2006 | bcli |
Stock Issued During Period For Private Placement In July
StockIssuedDuringPeriodForPrivatePlacementInJuly
|
99000 | USD |
| CY2006 | bcli |
Stock Issued During Period For Private Placement In September
StockIssuedDuringPeriodForPrivatePlacementInSeptember
|
225000 | USD |
| CY2006 | bcli |
Stock Issued During Period For Private Placement In December
StockIssuedDuringPeriodForPrivatePlacementInDecember
|
135000 | USD |
| CY2006 | bcli |
Forfeiture Of Options Granted To Employees
ForfeitureOfOptionsGrantedToEmployees
|
0 | USD |
| CY2006 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
0 | USD |
| CY2006 | bcli |
Amortization Of Deferred Stock Based Compensation Related To Shares And Options Granted To Employees
AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployees
|
1174000 | USD |
| CY2006 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
662000 | USD |
| us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
453000 | USD | |
| CY2006 | bcli |
Adjustments To Additional Paid In Capital Reclassification Due To Application
AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication
|
-7906000 | USD |
| bcli |
Adjustments To Additional Paid In Capital Reclassification Due To Application
AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication
|
7191000 | USD | |
| CY2006 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
164000 | USD |
| us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
1086000 | USD | |
| bcli |
Elimination Of Deferred Stock Compensation Due To Implementation
EliminationOfDeferredStockCompensationDueToImplementation
|
0 | USD | |
| bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
1168000 | USD | |
| bcli |
Adjustments To Additional Paid In Capital Warrant Issued To Convertible Note Holder
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder
|
11000 | USD | |
| bcli |
Adjustments To Additional Paid In Capital Warrant Issued To Loan Holder
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder
|
110000 | USD | |
| CY2007Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2428000 | USD |
| CY2008Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2076000 | USD |
| CY2007 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
1446000 | USD |
| CY2008 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
33000 | USD |
| CY2007 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
1232000 | USD |
| CY2008 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
731000 | USD |
| CY2007 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
214000 | USD |
| CY2008 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
0 | USD |
| CY2007 | bcli |
Stock Issued During Period Value Conversion Of Convertible Loans
StockIssuedDuringPeriodValueConversionOfConvertibleLoans
|
224000 | USD |
| CY2008 | bcli |
Stock Issued During Period Value Conversion Of Convertible Loans
StockIssuedDuringPeriodValueConversionOfConvertibleLoans
|
1276000 | USD |
| CY2007 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
407000 | USD |
| CY2007 | bcli |
Adjustments To Additional Paid In Capital Warrant Issued To Convertible Note Holder
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder
|
109000 | USD |
| CY2008 | bcli |
Adjustments To Additional Paid In Capital Subscription Of Shares For Private Placement
AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement
|
281000 | USD |
| CY2008 | bcli |
Stock Issued During Period For Private Placement Value Issues One
StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne
|
1500000 | USD |
| CY2007 | bcli |
Stock Issued During Period For Private Placement Value Issues One
StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne
|
2000000 | USD |
| CY2009Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1743000 | USD |
| CY2009 | bcli |
Adjustments To Additional Paid In Capital Subscription Of Shares For Private Placement
AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement
|
729000 | USD |
| CY2009 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
775000 | USD |
| CY2009 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
409000 | USD |
| CY2009 | bcli |
Stock Issued During Period Value Conversion Of Convertible Loans
StockIssuedDuringPeriodValueConversionOfConvertibleLoans
|
200000 | USD |
| CY2009 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
0 | USD |
| CY2009 | bcli |
Stock Issued During Period For Private Placement Value Issues One
StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne
|
1000 | USD |
| CY2010 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
96000 | USD |
| CY2010 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
388000 | USD |
| CY2010 | bcli |
Stock Issued During Period Value Conversion Of Convertible Note
StockIssuedDuringPeriodValueConversionOfConvertibleNote
|
135000 | USD |
| CY2010 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
11000 | USD |
| CY2010 | bcli |
Adjustments To Additional Paid In Capital Subscription Of Shares For Private Placement
AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement
|
455000 | USD |
| CY2010 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
201000 | USD |
| CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-459000 | USD |
| CY2010 | bcli |
Stock Issued During Period For Private Placement Value Issues One
StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne
|
1751000 | USD |
| CY2010 | bcli |
Stock Issued During Period Value Conversion Of Convertible Loans
StockIssuedDuringPeriodValueConversionOfConvertibleLoans
|
189000 | USD |
| CY2010 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
400000 | USD |
| CY2010 | bcli |
Stock Issued During Period Value Previously Subscribed Shares
StockIssuedDuringPeriodValuePreviouslySubscribedShares
|
0 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1488000 | USD |
| CY2011 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
449000 | USD |
| CY2011 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
1135000 | USD |
| CY2011 | bcli |
Stock Issued During Period Value Conversion Of Convertible Note
StockIssuedDuringPeriodValueConversionOfConvertibleNote
|
140000 | USD |
| CY2011 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
272000 | USD |
| CY2011 | bcli |
Stock Issued During Period For Private Placement Value
StockIssuedDuringPeriodForPrivatePlacementValue
|
3602000 | USD |
| CY2011 | bcli |
Stock Issued During Period Value Previously Subscribed Shares
StockIssuedDuringPeriodValuePreviouslySubscribedShares
|
24000 | USD |
| CY2012 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
195000 | USD |
| CY2012 | bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
560000 | USD |
| CY2012 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
9000 | USD |
| CY2012 | bcli |
Stock Issued During Period For Private Placement Value
StockIssuedDuringPeriodForPrivatePlacementValue
|
5023000 | USD |
| us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
172000 | USD | |
| bcli |
Stock Based Compensation Related To Options Granted To Employees And Directors Value
StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue
|
514000 | USD | |
| bcli |
Stock Issued During Period For Private Placement Value
StockIssuedDuringPeriodForPrivatePlacementValue
|
250000 | USD | |
| bcli |
Stock Issued During Period Value Conversion Of Convertible Loans
StockIssuedDuringPeriodValueConversionOfConvertibleLoans
|
30000 | USD | |
| CY2008 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3000 | USD |
| CY2010 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
77000 | USD |
| CY2011 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
243000 | USD |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-17000 | USD | |
| CY2002 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26000 | USD |
| CY2003 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-47000 | USD |
| CY2004 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-73000 | USD |
| CY2005 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18840000 | USD |
| CY2006 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3317000 | USD |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-3924000 | USD | |
| CY2007 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6244000 | USD |
| CY2008 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3472000 | USD |
| CY2009 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1781000 | USD |
| CY2010 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2419000 | USD |
| CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3430000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
137000 | USD |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7000 | USD | |
| CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3918000 | USD |
| us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
57000 | USD | |
| us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
36000 | USD | |
| us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
16000 | USD | |
| CY2013Q2 | us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
17000 | USD |
| CY2012Q2 | us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
39000 | USD |
| us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
1208000 | USD | |
| CY2013Q2 | us-gaap |
Severance Costs1
SeveranceCosts1
|
9000 | USD |
| CY2012Q2 | us-gaap |
Severance Costs1
SeveranceCosts1
|
0 | USD |
| us-gaap |
Severance Costs1
SeveranceCosts1
|
24000 | USD | |
| CY2013Q2 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
| CY2012Q2 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
451000 | USD | |
| CY2013Q2 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | USD |
| CY2012Q2 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | USD |
| us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
795000 | USD | |
| CY2013Q2 | bcli |
Expenses Related To Shares And Options Granted To Service Providers
ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders
|
74000 | USD |
| CY2012Q2 | bcli |
Expenses Related To Shares And Options Granted To Service Providers
ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders
|
4000 | USD |
| bcli |
Expenses Related To Shares And Options Granted To Service Providers
ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders
|
21883000 | USD | |
| CY2013Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
311000 | USD |
| CY2012Q2 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
136000 | USD |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
7895000 | USD | |
| CY2013Q2 | bcli |
Increase In Accounts Receivable And Prepaid Expenses
IncreaseInAccountsReceivableAndPrepaidExpenses
|
95000 | USD |
| CY2012Q2 | bcli |
Increase In Accounts Receivable And Prepaid Expenses
IncreaseInAccountsReceivableAndPrepaidExpenses
|
-72000 | USD |
| bcli |
Increase In Accounts Receivable And Prepaid Expenses
IncreaseInAccountsReceivableAndPrepaidExpenses
|
755000 | USD | |
| CY2013Q2 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
127000 | USD |
| CY2012Q2 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
190000 | USD |
| us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
846000 | USD | |
| CY2013Q2 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
12000 | USD |
| CY2012Q2 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-30000 | USD |
| us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
1333000 | USD | |
| CY2013Q2 | bcli |
Erosion Of Restricted Cash
ErosionOfRestrictedCash
|
0 | USD |
| CY2012Q2 | bcli |
Erosion Of Restricted Cash
ErosionOfRestrictedCash
|
0 | USD |
| bcli |
Erosion Of Restricted Cash
ErosionOfRestrictedCash
|
6000 | USD | |
| CY2013Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-1063000 | USD |
| CY2012Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-419000 | USD |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-15996000 | USD | |
| CY2013Q2 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
0 | USD |
| CY2012Q2 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
0 | USD |
| us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-23000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
271000 | USD | |
| us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
46000 | USD | |
| bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
0 | USD | |
| CY2013Q2 | bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
-3000 | USD |
| bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
-26000 | USD | |
| CY2013Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1063000 | USD |
| CY2012Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-419000 | USD |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-16019000 | USD | |
| us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
50000 | USD | |
| us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
77000 | USD | |
| us-gaap |
Severance Costs1
SeveranceCosts1
|
7000 | USD | |
| us-gaap |
Severance Costs1
SeveranceCosts1
|
1000 | USD | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD | |
| us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | USD | |
| us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | USD | |
| bcli |
Expenses Related To Shares And Options Granted To Service Providers
ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders
|
202000 | USD | |
| bcli |
Expenses Related To Shares And Options Granted To Service Providers
ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders
|
8000 | USD | |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
514000 | USD | |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
313000 | USD | |
| bcli |
Increase In Accounts Receivable And Prepaid Expenses
IncreaseInAccountsReceivableAndPrepaidExpenses
|
-33000 | USD | |
| bcli |
Increase In Accounts Receivable And Prepaid Expenses
IncreaseInAccountsReceivableAndPrepaidExpenses
|
177000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
15000 | USD | |
| us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
44000 | USD | |
| bcli |
Erosion Of Restricted Cash
ErosionOfRestrictedCash
|
0 | USD | |
| bcli |
Erosion Of Restricted Cash
ErosionOfRestrictedCash
|
0 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-1733000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-1165000 | USD | |
| us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
0 | USD | |
| us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
0 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1733000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1165000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
66000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
61000 | USD | |
| CY2013Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
46000 | USD |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1289000 | USD | |
| us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD | |
| us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD | |
| CY2013Q2 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-6000 | USD | |
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
-989000 | USD | |
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
0 | USD | |
| us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
1780000 | USD | |
| bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
-9000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
914000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-61000 | USD | |
| CY2013Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-57000 | USD |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-3089000 | USD | |
| us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
0 | USD | |
| us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
0 | USD | |
| CY2013Q2 | us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
0 | USD |
| us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
-16000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
914000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-61000 | USD | |
| CY2013Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-57000 | USD |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3105000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
250000 | USD | |
| us-gaap |
Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
|
601000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
257000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
146000 | USD | |
| CY2013Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7000 | USD |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
19836000 | USD | |
| us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
0 | USD | |
| us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
0 | USD | |
| CY2013Q2 | us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
0 | USD |
| us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
43000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD | |
| CY2013Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
17592000 | USD | |
| us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
0 | USD | |
| us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
0 | USD | |
| CY2013Q2 | us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
0 | USD |
| us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
2061000 | USD | |
| us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7000 | USD | |
| us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
146000 | USD | |
| CY2013Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7000 | USD |
| us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
784000 | USD | |
| us-gaap |
Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
|
0 | USD | |
| us-gaap |
Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
|
0 | USD | |
| CY2013Q2 | us-gaap |
Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
|
0 | USD |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
257000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
146000 | USD | |
| CY2013Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7000 | USD |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
19879000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-562000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1080000 | USD | |
| CY2013Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1113000 | USD |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
755000 | USD | |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1923000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1868000 | USD |
| CY2000Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
| CY2012Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
843000 | USD |
| CY2012Q2 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2012Q2 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
0 | USD |
| CY2012Q2 | bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
0 | USD |
| CY2012Q2 | us-gaap |
Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
0 | USD |
| CY2012Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-9000 | USD |
| CY2012Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2012Q2 | us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
0 | USD |
| CY2012Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
126000 | USD |
| CY2012Q2 | us-gaap |
Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
|
0 | USD |
| CY2012Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
126000 | USD |
| CY2012Q2 | us-gaap |
Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
|
0 | USD |
| CY2012Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
126000 | USD |
| CY2012Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-302000 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1145000 | USD |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD | |
| CY2013Q2 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| CY2012Q2 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1864000 | USD | |
| CY2012Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
9000 | USD |
| CY2013Q2 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
8000 | USD |
| CY2009 | bcli |
Number Of Days Of Restriction To Sell Shares In Open Market
NumberOfDaysOfRestrictionToSellSharesInOpenMarket
|
185 days | |
| CY2012Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4900000 | USD |
| CY2004Q2 | bcli |
Common Stock Transferred As Per Purchase Agreement
CommonStockTransferredAsPerPurchaseAgreement
|
6880000 | shares |
| CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1082000 | USD |
| us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
between 1-for-10 and 1-for-20 | ||
| CY2009Q4 | bcli |
Research License Agreement Expenses Paid
ResearchLicenseAgreementExpensesPaid
|
400000 | USD |
| CY2011Q1 | bcli |
Research License Payments Made As Per Settlement Agreement
ResearchLicensePaymentsMadeAsPerSettlementAgreement
|
5000 | USD |
| CY2009 | bcli |
Shares Granted As Per Research And License Agreement
SharesGrantedAsPerResearchAndLicenseAgreement
|
1120000 | shares |
| CY2011Q1 | bcli |
Number Of Shares Sold By Purchaser As Permitted By Settlement Agreement
NumberOfSharesSoldByPurchaserAsPermittedBySettlementAgreement
|
167530 | shares |
| CY2011Q1 | bcli |
Proceeds From Shares Sold By Purchaser As Permitted By Settlement Agreement
ProceedsFromSharesSoldByPurchaserAsPermittedBySettlementAgreement
|
35000 | USD |
| CY2011Q1 | bcli |
Total Value Of Shares Sold By Purchaser
TotalValueOfSharesSoldByPurchaser
|
235000 | USD |
| CY2009Q4 | bcli |
Obligation Amount To Fund Extended Research Period
ObligationAmountToFundExtendedResearchPeriod
|
1140000 | USD |
| CY2009 | bcli |
Research And Development Expenses Reversed
ResearchAndDevelopmentExpensesReversed
|
760000 | USD |
| CY2009 | bcli |
Stock Based Compensation Related To Shares Granted Under Research License Agreement
StockBasedCompensationRelatedToSharesGrantedUnderResearchLicenseAgreement
|
51000 | USD |
| CY2009 | bcli |
Research License Interest Rate
ResearchLicenseInterestRate
|
32000 | USD |
| bcli |
Percentage Of Royalty Payment If Licensed Product Covered By Valid Claim Or Orphan Drug Status
PercentageOfRoyaltyPaymentIfLicensedProductCoveredByValidClaimOrOrphanDrugStatus
|
0.05 | pure | |
| bcli |
Percentage Of Royalty Payment If Licensed Product Not Covered By Valid Claim Or Orphan Drug Status
PercentageOfRoyaltyPaymentIfLicensedProductNotCoveredByValidClaimOrOrphanDrugStatus
|
0.03 | pure | |
| bcli |
Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status
ValidityOfRoyaltyPaymentNotCoveredByValidClaimOrOrphanDrugStatus
|
P15Y | ||
| CY2009 | bcli |
Proceeds From Sale Of Shares Are Less Than240 Conditions
ProceedsFromSaleOfSharesAreLessThan240Conditions
|
Company would pay to Ramot the difference between the proceeds that Ramot has received from sales of the shares up to such date together with the September Payment (if any) that has been transferred to Ramot up to such date, and $240. | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
0.1778 | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2011Q1 | bcli |
Amount Due To Investors
AmountDueToInvestors
|
22000 | USD |
| CY2009 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
1120000 | shares |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
147989000 | USD |
| bcli |
Number Of Warrants Issued Total
NumberOfWarrantsIssuedTotal
|
95095119 | shares | |
| CY2007Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
5000000 | USD |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
4595924 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.1803 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.2656 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.1800 | ||
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.2224 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4751665 | shares |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
4626666 | shares | |
| bcli |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross
|
0 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
6667 | shares | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
9371664 | shares |
| bcli |
Warrant Exercised Total
WarrantExercisedTotal
|
16468540 | shares | |
| bcli |
Warrant Forfeited Total
WarrantForfeitedTotal
|
27401794 | shares | |
| CY2013Q2 | bcli |
Warrants Outstanding Total
WarrantsOutstandingTotal
|
51224785 | shares |
| CY2013Q2 | bcli |
Warrants Exercisable Total
WarrantsExercisableTotal
|
50697007 | shares |
